Drugs During Pregnancy and Lactation : (Record no. 861441)

001 - CONTROL NUMBER
control field EBL1798300
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
additional material characteristics m d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr -n---------
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 141019s2014||||||| s|||||||||||eng|d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780124079014
Terms of availability 161.91 (UA)
035 ## - SYSTEM CONTROL NUMBER
System control number (AU-PeEL)1798300
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)892240074
040 ## - CATALOGING SOURCE
Original cataloging agency AU-PeEL
Language of cataloging eng
Transcribing agency AU-PeEL
Modifying agency AU-PeEL
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RG627.6 .D79 D796 2014
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 618.32
090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (OCLC)
Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) RG627.6 .D79 D796 2014
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Schaefer, Christof.
245 10 - TITLE STATEMENT
Title Drugs During Pregnancy and Lactation :
Remainder of title Treatment Options and Risk Assessment
250 ## - EDITION STATEMENT
Edition statement 3rd ed.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Burlington :
Name of publisher, distributor, etc Elsevier Science,
Date of publication, distribution, etc 2014.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (919 p.)
490 0# - SERIES STATEMENT
Series statement eBooks on Demand
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Cover; Drugs During Pregnancy and Lactation; Copyright; Contents; List of Contributors; Preface; Disclaimer; 1 - General commentary on drug therapy and drug risks in ­pregnancy; 1.1 Introduction; 1.2 Development and health; 1.3 Reproductive stages; 1.4 Reproductive and developmental toxicology; 1.5 Basic principles of drug-induced reproductive and developmental toxicology; 1.6 Effects and manifestations; 1.7 Pharmacokinetics of drugs in pregnancy; 1.8 Mechanisms of developmental toxic agents; 1.9 Causes of developmental disorders; 1.10 Embryo/fetotoxic risk assessment and plausibility
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 1.11 Classification of drugs used in pregnancy1.12 Paternal use of medicinal products; 1.13 Communicating the risk of drug use in pregnancy; 1.14 Risk communication prior to pharmacotherapeutic choice; 1.15 Risk communication regarding the safety of drugs already used in pregnancy; 1.16 Teratology information centers; References; 2 - Specific drug therapiesduring pregnancy; 2.1 - Analgesics, non-steroidal anti-­inflammatory drugs (NSAIDs), muscle relaxants, and antigout medications; 2.1.1 Paracetamol (acetaminophen); 2.1.2 Acetylsalicylic acid; 2.1.3 Pyrazolone compounds and phenylbutazone
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 2.1.4 Analgesic drug combination products and drugs used for osteoarthritis2.1.5 Opioid agonists and antagonists and other centrally acting analgesics; 2.1.6 Non-steroidal anti-inflammatory and antirheumatic drugs; 2.1.7 Migraine therapy; 2.1.8 Muscle relaxants and other analgesics; 2.1.9 Antigout preparations; References; 2.2 - Allergy and hyposensitization therapy; 2.2.1 Antihistamines (H1-blocker); 2.2.2 Hyposensitization therapy; 2.2.3 C1-Esterase inhibitor deficiency; References; 2.3 - Antiasthmatic and cough ­medication; 2.3.1 Selective β2-adrenergic agonists
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 2.3.2 Inhaled corticosteroids (ICSs)2.3.3 Theophylline; 2.3.4 Leukotriene antagonists; 2.3.5 Mast cell stabilizers (inhibitors); 2.3.6 Anticholinergics; 2.3.7 Omalizumab and roflumilast; 2.3.8 Expectorants and mucolytic agents; 2.3.9 Antitussives; 2.3.10 Non-selective β-adrenergic agonists; References; 2.4 - Nausea and vomiting in pregnancy; 2.4.1 Treatment options; 2.4.2 Complementary treatment options; 2.4.3 Pharmacological treatment options; 2.4.4 Dopamine antagonists; 2.4.5 Pyridoxine (vitamin B6); 2.4.6 Vitamin B1; 2.4.7 Serotonin antagonists; 2.4.8 Glucocorticoids
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 2.4.9 Other antiemeticsSummary; References; 2.5 - Gastro-intestinal medications, hypolipidemic agents and ­spasmolytics; 2.5.1 Antacids; 2.5.2 Sucralfate and pirenzepine; 2.5.3 H2 receptor antagonists; 2.5.4 Proton pump inhibitors; 2.5.5 Bismuth salts; 2.5.6 Helicobacter pylori therapy; 2.5.7 Digestives and carminatives; 2.5.8 Atropine and other anticholinergic spasmolytics; 2.5.9 Cholinergics; 2.5.10 Constipation during pregnancy; 2.5.11 Antidiarrheal agents; 2.5.12 Medications for inflammatory bowel disease; 2.5.13 Chenodeoxycholic acid and ursodeoxycholic acid; 2.5.14 Lipid lowering agents
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 2.5.15 Appetite suppressants, weight loss medications, and obesity
520 ## - SUMMARY, ETC.
Summary, etc Drugs During Pregnancy and Lactation, 3rd Edition is a quick and reliable reference for all those working in disciplines related to fertility, pregnancy, lactation, child health and human genetics who prescribe or deliver medicinal products, and to those who evaluate health and safety risks. Each chapter contains twofold information regarding drugs that are appropriate for prescription during pregnancy and an assessment of the risk of a drug when exposure during pregnancy has already occurred. Thoroughly updated with current regulations, references to the latest pharmacological data, and new
588 ## -
-- Description based upon print version of record.
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Fetus -- Effect of drugs on -- Handbooks, manuals, etc.
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Newborn infants -- Effect of drugs on -- Handbooks, manuals, etc.
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Obstetrical pharmacology -- Handbooks, manuals, etc.
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pregnant women -- Drug use.
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pregnant women -- Medical care.
655 #0 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Peters, Paul W.J.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Miller, Richard K.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Print version:
Main entry heading Schaefer, Christof
Title Drugs During Pregnancy and Lactation : Treatment Options and Risk Assessment
Place, publisher, and date of publication Burlington : Elsevier Science,c2014
International Standard Book Number 9780124080782
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://uttyler.eblib.com/patron/FullRecord.aspx?p=1798300">http://uttyler.eblib.com/patron/FullRecord.aspx?p=1798300</a>
Link text Click here to view this ebook.
901 ## - LOCAL DATA ELEMENT A, LDA (RLIN)
Platform EBL
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Electronic Book
Source of classification or shelving scheme
Holdings
Withdrawn status Lost item Source of classification or shelving scheme Damaged status Not for loan Permanent Location Current Location Shelving location Date acquired Full call number Barcode Date last seen Uniform Resource Identifier Price effective from Koha item type
          UT Tyler Online UT Tyler Online Online 2014-10-20 RG627.6 .D79 D796 2014 EBL1798300 2014-10-20 http://uttyler.eblib.com/patron/FullRecord.aspx?p=1798300 2014-10-20 Electronic Book